DF/HCC Kidney Cancer SPORE - CEP & DRP RFAs

JULY 19, 2021

DF/HCC Kidney Cancer Program has extended the application deadline for its Kidney Cancer SPORE Career Enhancement and Developmental Research Project Awards, with applications now due on August 18, 2021. Read more about these awards below for more information.

Career Enhancement Program RFA

The Kidney Cancer Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Career Enhancement Program (CEP) in Kidney Cancer Research.

 

REQUEST FOR APPLICATIONS: Career Enhancement Awards in Kidney Cancer Research
AWARD AMOUNT:

Two years of funding at up to $50,000 per year (exclusive of F&A costs )

APPLICATION DEADLINE: On or before Wednesday, August 18, 2021 at 5PM *Extended*

The Kidney Cancer SPORE of the Dana Farber/Harvard Cancer Center, under the leadership of Drs. David McDermott and William Kaelin seeks applications for the Career Enhancement Program in Kidney Cancer Research. Eligible candidates are those who are in their final year of clinical fellowship or postdoctoral fellowship (MD, PhD or MD/PhD required) or within their first 3 years on staff. A prior track record in kidney cancer research is preferred but not required.

The awardee will receive up to two years of funding at up to $50,000 per year (exclusive of F&A costs ), which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals. Funding sources may include Kidney Cancer SPORE (P50CA101942-13), corporate and sundry monies. Depending on the source of funding for each award, awarded F&A will vary from 10% to your DHHS institutional negotiated rate. Therefore, we ask that F&A NOT be included in the requested budget and that applications must have institutional sign-off. Funding provided needs to be spent within the budgeted time period. Proposals should present a two year research plan with clearly defined milestones. Applicants will be evaluated using the 5 point NIH scale according to the following criteria-

  1. The scientific merit/quality of the proposal (coherent presentation, candidate's own work, kidney cancer focus, translational nature)
  2. The quality of the candidate (quality of previous work; potential for academic career in kidney cancer)
  3. The quality of the research environment (mentor support and track record, resources available)

Consideration will also be given to investigators expressing interest in shifting their research focus to kidney cancer. In this instance, items that will also be considered include:

  1. The seriousness of the commitment to translational research in kidney cancer
  2. The willingness of the individual to continue a productive relationship with the SPORE and the Kidney Cancer Program

The awardee will be expected to become a member of the DF/HCC Kidney Cancer Program and participate in Program activities including monthly research conferences, yearly half-day seminars, and the annual retreat. Women and minority candidates are encouraged to apply. Applications should be sent electronically to Tara Johnston, tjohnst1@bidmc.harvard.edu, no later than 5 PM on 08/18/2021

Applications must contain the following components using the PHS 398 forms:

  1. Cover* with Institutional Approval (Statement of Intent if outside BIDMC)
  2. Abstract of proposed research
  3. Research Proposal: Includes 1) Specific Aims, 2) Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages, exclusive of the proposed milestones and literature cited.
  4. Applicants Career Goals (1 page)
  5. Research and Environment for proposed research
  6. Mentor(s) Letter of Support
  7. Applicant’s and Mentor’s current NIH Biosketch
  8. Applicant’s and Mentors NIH New Other Support Page
  9. Proposed Budget NIH 398 form: must not exceed $50,000/year (exclusive of F&A). Funds cannot be used for the purchase of any large equipment.
  10. Budget Justification
  11. NIH checklist for Institution rate
  12. IRB/IACUC approval documents (if applicable)
  13. Human Subject Training Certificate (if applicable)

*Please include Title, PI, and research administrator contact on cover sheet and submit all documents as one pdf file. Pages should be numbered.

Anticipated Award Dates: 09/01/2021-08/31/2022
We anticipate being able to support 1-2 projects for that period

Hide

Developmental Research Project RFA

The Kidney Cancer Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Developmental Research Project Awards (DRP) in Kidney Cancer Research.

 

REQUEST FOR APPLICATIONS: Developmental Research Project Awards in Kidney Cancer Research
AWARD AMOUNT:

Up to $50,000 in direct costs (F&A at the institutions federally negotiated rate) for one year

APPLICATION DEADLINE: On or before Wednesday, August 18, 2021 at 12PM *Extended*

The Kidney Cancer SPORE of the Dana Farber/Harvard Cancer Center, under the leadership of Drs. David McDermott and William Kaelin, seeks applications for funding of research on kidney cancer. Funding will be provided through the Kidney Cancer Specialized Program of Research Excellence (SPORE) mechanism, a National Cancer Institute sponsored program (P50CA101942-17). Applications must include one investigator on the faculty at Harvard Medical School at the level of Instructor or higher.

While the proposed research can be basic or clinical, bench to bedside and bedside to bench strategies need to be addressed, since the purpose of this program is to promote translational research in kidney cancer. Applications will be judged on their scientific merit, relevance to kidney cancer, potential for future translation to clinical application, qualifications of the research team and the potential fit within the overall activities of the DF/HCC Kidney Cancer Program/Kidney Cancer SPORE. Funding will be up to $50,000 in direct costs (F&A at the institutions federally negotiated rate) for one year. Although the opportunity exists for extending funding beyond one year, proposals should, in general, focus on a year’s worth of research. Applications should be sent electronically in one pdf to Tara Johnston at tjohnst1@bidmc.harvard.edu no later than noon on 08/18/2021. A prior track record in kidney cancer research is preferred but not necessary. Minority and women applicants are strongly encouraged to apply. 

Applications must contain the following components on PHS 398 Forms: 

  1. Institutional Signature provided on a Letter of Intent to collaborate for non BIDMC applicants
  2. Cover letter: Include Title of proposal, PI, Institution and research administration contact.
  3. Abstract: Include of proposed research
  4. Research Proposal: Include 1) Specific Aims 2) Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages. Reference and Budget pages are not included in this page limit. Appendix material not required.
  5. Translational Goals of the project, potential application to kidney cancer and anticipated timeline (1 page)
  6. NIH Biosketch and New NIH Other Support: Current NIH Biosketch and any collaborators including funding sources 
  7. Budget Request and Justification: Must be submitted on the NIH 398 budget form and must not exceed Direct Costs of $50,000. Funds cannot be used for the purchase of any large equipment.
  8. NIH Checklist
  9. IRB/IACUC approval documents (if applicable)
  10. Human Subject Training Certificate (if applicable)
  11. Submit all documents as one pdf file. Pages should be numbered.

Anticipated Award Dates: 09/01/2021 – 08/31/22

We anticipate being able to fund 1-2 projects for that project period.

Hide